An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome.
Adult
Aged
Cohort Studies
Colorectal Neoplasms
/ etiology
Colorectal Neoplasms, Hereditary Nonpolyposis
/ complications
DNA Mismatch Repair
DNA-Binding Proteins
/ genetics
Female
Genetic Predisposition to Disease
/ genetics
Germ-Line Mutation
Humans
Incidence
Male
Middle Aged
Mismatch Repair Endonuclease PMS2
/ genetics
Mutation
Risk Assessment
/ methods
Risk Factors
HNPCC
MSH6
PMS2
bMMRD
colon cancer risk
Journal
Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
24
01
2019
accepted:
30
05
2019
pubmed:
18
6
2019
medline:
2
5
2020
entrez:
18
6
2019
Statut:
ppublish
Résumé
Biallelic pathogenic variants in the mismatch repair (MMR) genes cause a recessive childhood cancer predisposition syndrome known as constitutional mismatch repair deficiency (CMMRD). Family members with a heterozygous MMR variant have Lynch syndrome. We aimed at estimating cancer risk in these heterozygous carriers as a novel approach to avoid complicated statistical methods to correct for ascertainment bias. Cumulative colorectal cancer incidence was estimated in a cohort of PMS2- and MSH6-associated families, ascertained by the CMMRD phenotype of the index, by using mutation probabilities based on kinship coefficients as analytical weights in a proportional hazard regression on the cause-specific hazards. Confidence intervals (CIs) were obtained by bootstrapping at the family level. The estimated cumulative colorectal cancer risk at age 70 years for heterozygous PMS2 variant carriers was 8.7% (95% CI 4.3-12.7%) for both sexes combined, and 9.9% (95% CI 4.9-15.3%) for men and 5.9% (95% CI 1.6-11.1%) for women separately. For heterozygous MSH6 variant carriers these estimates are 11.8% (95% CI 4.5-22.7%) for both sexes combined, 10.0% (95% CI 1.83-24.5%) for men and 11.7% (95% CI 2.10-26.5%) for women. Our findings are consistent with previous reports that used more complex statistical methods to correct for ascertainment bias. These results underline the need for MMR gene-specific surveillance protocols for Lynch syndrome.
Identifiants
pubmed: 31204389
doi: 10.1038/s41436-019-0577-z
pii: S1098-3600(21)01215-6
doi:
Substances chimiques
DNA-Binding Proteins
0
G-T mismatch-binding protein
0
PMS2 protein, human
EC 3.6.1.-
Mismatch Repair Endonuclease PMS2
EC 3.6.1.3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM